Loading…
Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases
Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempti...
Saved in:
Published in: | Breast care (Basel, Switzerland) Switzerland), 2020-04, Vol.15 (2), p.148-156 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c490t-d1f12a80dd6e10a9d3c85d4d2eb6e38e1838fdb3f90929fbdd1d8f802cfde5043 |
---|---|
cites | cdi_FETCH-LOGICAL-c490t-d1f12a80dd6e10a9d3c85d4d2eb6e38e1838fdb3f90929fbdd1d8f802cfde5043 |
container_end_page | 156 |
container_issue | 2 |
container_start_page | 148 |
container_title | Breast care (Basel, Switzerland) |
container_volume | 15 |
creator | Buonomo, Barbara Brunello, Antonella Noli, Stefania Miglietta, Loredana Del Mastro, Lucia Lambertini, Matteo Peccatori, Fedro Alessandro |
description | Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempting conception. Nevertheless, when conception occurs inadvertently during tamoxifen treatment, the effects on the fetus and on the course of pregnancy are still not completely known. Here, we report 3 cases of young women who accidentally became pregnant while taking tamoxifen and perform a systematic review of the literature to provide more elements for better and clear multidisciplinary counselling of women facing this challenging situation. |
doi_str_mv | 10.1159/000501473 |
format | article |
fullrecord | <record><control><sourceid>pubmed_karge</sourceid><recordid>TN_cdi_karger_primary_501473</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32398983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-d1f12a80dd6e10a9d3c85d4d2eb6e38e1838fdb3f90929fbdd1d8f802cfde5043</originalsourceid><addsrcrecordid>eNptkM1Lw0AUxBdRbK0evIssePIQ3c3mY9eDUEP9gBal1nPYZN-m0TYJu2lt_3sjsUHB0xuY38yDQeiUkitKfXFNCPEJ9UK2h_o0CKjDOPH3dzoUtIeOrH0nxAtYGByiHnOZ4IKzPprM5LLc5BoKPNpUpV0ZwGpl8iLDLwayQhbp9gYP8evW1rCUdZ7iKaxz-MSyUHg2NwB4UjahSFqwx-hAy4WFk587QG_3o1n06IyfH56i4dhJPUFqR1FNXcmJUgFQIoViKfeVp1xIAmAcKGdcq4RpQYQrdKIUVVxz4qZagU88NkC3bW-1SpagUihqIxdxZfKlNNu4lHn81ynyeZyV6zh0iRdy1hRctgWpKa01oLssJfH3pnG3acOe_37WkbsRG-CsBT6kycB0QJe_-Ne-m0YtEVdKsy8R4YgW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases</title><source>PubMed Central Free</source><creator>Buonomo, Barbara ; Brunello, Antonella ; Noli, Stefania ; Miglietta, Loredana ; Del Mastro, Lucia ; Lambertini, Matteo ; Peccatori, Fedro Alessandro</creator><creatorcontrib>Buonomo, Barbara ; Brunello, Antonella ; Noli, Stefania ; Miglietta, Loredana ; Del Mastro, Lucia ; Lambertini, Matteo ; Peccatori, Fedro Alessandro</creatorcontrib><description>Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempting conception. Nevertheless, when conception occurs inadvertently during tamoxifen treatment, the effects on the fetus and on the course of pregnancy are still not completely known. Here, we report 3 cases of young women who accidentally became pregnant while taking tamoxifen and perform a systematic review of the literature to provide more elements for better and clear multidisciplinary counselling of women facing this challenging situation.</description><identifier>ISSN: 1661-3791</identifier><identifier>EISSN: 1661-3805</identifier><identifier>DOI: 10.1159/000501473</identifier><identifier>PMID: 32398983</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger GmbH</publisher><subject>Systematic Review</subject><ispartof>Breast care (Basel, Switzerland), 2020-04, Vol.15 (2), p.148-156</ispartof><rights>2019 S. Karger AG, Basel</rights><rights>Copyright © 2019 by S. Karger AG, Basel.</rights><rights>Copyright © 2019 by S. Karger AG, Basel 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-d1f12a80dd6e10a9d3c85d4d2eb6e38e1838fdb3f90929fbdd1d8f802cfde5043</citedby><cites>FETCH-LOGICAL-c490t-d1f12a80dd6e10a9d3c85d4d2eb6e38e1838fdb3f90929fbdd1d8f802cfde5043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204783/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204783/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32398983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buonomo, Barbara</creatorcontrib><creatorcontrib>Brunello, Antonella</creatorcontrib><creatorcontrib>Noli, Stefania</creatorcontrib><creatorcontrib>Miglietta, Loredana</creatorcontrib><creatorcontrib>Del Mastro, Lucia</creatorcontrib><creatorcontrib>Lambertini, Matteo</creatorcontrib><creatorcontrib>Peccatori, Fedro Alessandro</creatorcontrib><title>Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases</title><title>Breast care (Basel, Switzerland)</title><addtitle>Breast Care</addtitle><description>Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempting conception. Nevertheless, when conception occurs inadvertently during tamoxifen treatment, the effects on the fetus and on the course of pregnancy are still not completely known. Here, we report 3 cases of young women who accidentally became pregnant while taking tamoxifen and perform a systematic review of the literature to provide more elements for better and clear multidisciplinary counselling of women facing this challenging situation.</description><subject>Systematic Review</subject><issn>1661-3791</issn><issn>1661-3805</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNptkM1Lw0AUxBdRbK0evIssePIQ3c3mY9eDUEP9gBal1nPYZN-m0TYJu2lt_3sjsUHB0xuY38yDQeiUkitKfXFNCPEJ9UK2h_o0CKjDOPH3dzoUtIeOrH0nxAtYGByiHnOZ4IKzPprM5LLc5BoKPNpUpV0ZwGpl8iLDLwayQhbp9gYP8evW1rCUdZ7iKaxz-MSyUHg2NwB4UjahSFqwx-hAy4WFk587QG_3o1n06IyfH56i4dhJPUFqR1FNXcmJUgFQIoViKfeVp1xIAmAcKGdcq4RpQYQrdKIUVVxz4qZagU88NkC3bW-1SpagUihqIxdxZfKlNNu4lHn81ynyeZyV6zh0iRdy1hRctgWpKa01oLssJfH3pnG3acOe_37WkbsRG-CsBT6kycB0QJe_-Ne-m0YtEVdKsy8R4YgW</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Buonomo, Barbara</creator><creator>Brunello, Antonella</creator><creator>Noli, Stefania</creator><creator>Miglietta, Loredana</creator><creator>Del Mastro, Lucia</creator><creator>Lambertini, Matteo</creator><creator>Peccatori, Fedro Alessandro</creator><general>S. Karger GmbH</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20200401</creationdate><title>Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases</title><author>Buonomo, Barbara ; Brunello, Antonella ; Noli, Stefania ; Miglietta, Loredana ; Del Mastro, Lucia ; Lambertini, Matteo ; Peccatori, Fedro Alessandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-d1f12a80dd6e10a9d3c85d4d2eb6e38e1838fdb3f90929fbdd1d8f802cfde5043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Systematic Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buonomo, Barbara</creatorcontrib><creatorcontrib>Brunello, Antonella</creatorcontrib><creatorcontrib>Noli, Stefania</creatorcontrib><creatorcontrib>Miglietta, Loredana</creatorcontrib><creatorcontrib>Del Mastro, Lucia</creatorcontrib><creatorcontrib>Lambertini, Matteo</creatorcontrib><creatorcontrib>Peccatori, Fedro Alessandro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Breast care (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buonomo, Barbara</au><au>Brunello, Antonella</au><au>Noli, Stefania</au><au>Miglietta, Loredana</au><au>Del Mastro, Lucia</au><au>Lambertini, Matteo</au><au>Peccatori, Fedro Alessandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases</atitle><jtitle>Breast care (Basel, Switzerland)</jtitle><addtitle>Breast Care</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>15</volume><issue>2</issue><spage>148</spage><epage>156</epage><pages>148-156</pages><issn>1661-3791</issn><eissn>1661-3805</eissn><abstract>Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempting conception. Nevertheless, when conception occurs inadvertently during tamoxifen treatment, the effects on the fetus and on the course of pregnancy are still not completely known. Here, we report 3 cases of young women who accidentally became pregnant while taking tamoxifen and perform a systematic review of the literature to provide more elements for better and clear multidisciplinary counselling of women facing this challenging situation.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger GmbH</pub><pmid>32398983</pmid><doi>10.1159/000501473</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1661-3791 |
ispartof | Breast care (Basel, Switzerland), 2020-04, Vol.15 (2), p.148-156 |
issn | 1661-3791 1661-3805 |
language | eng |
recordid | cdi_karger_primary_501473 |
source | PubMed Central Free |
subjects | Systematic Review |
title | Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A13%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tamoxifen%20Exposure%20during%20Pregnancy:%20A%20Systematic%20Review%20and%20Three%20More%20Cases&rft.jtitle=Breast%20care%20(Basel,%20Switzerland)&rft.au=Buonomo,%20Barbara&rft.date=2020-04-01&rft.volume=15&rft.issue=2&rft.spage=148&rft.epage=156&rft.pages=148-156&rft.issn=1661-3791&rft.eissn=1661-3805&rft_id=info:doi/10.1159/000501473&rft_dat=%3Cpubmed_karge%3E32398983%3C/pubmed_karge%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-d1f12a80dd6e10a9d3c85d4d2eb6e38e1838fdb3f90929fbdd1d8f802cfde5043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/32398983&rfr_iscdi=true |